Opposing roles of RAGE and Myd88 signaling in extensive liver resection

FASEB Journal

Volumn 26, Issue 2, 2012, Pages 882-893

  Zeng, Shan ^a,c   Zhang, Qing Yin ^a   Huang, Jianzhong ^a   Vedantham, Srinivasan ^b   Rosario, Rosa ^b   Ananthakrishnan, Radha ^b   Yan, Shi Fang ^b   Ramasamy, Ravichandran ^b   DeMatteo, Ronald P ^c   Emond, Jean C ^a   Friedman, Richard A ^a   Schmidt, Ann Marie ^b  

^a Columbia University ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Inflammation; Nuclear factor B; Pim1; Proliferation; Stat 3 phosphorylation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYCLIN D1; GLYOXALASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE PIM 1; STAT3 PROTEIN; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEPATECTOMY; HEPATOCYTES; IMMUNITY, INNATE; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-PIM-1; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

MURINAE; MUS;

EID: 84863062536     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-192997     Document Type: Article

References (42)

1. Samstein, B., and Emond, J. (2001) Liver transplants from living related donors. Ann. Rev. Med. 52, 147-160 (Pubitemid 32195318)
2. Koniaris, L. G., McKillop, I. H., Schwartz, S. I., and Zimmers, T. A. (2003) Liver regeneration. J. Am. Coll. Surg. 197, 634-659 (Pubitemid 38223851)
3. Panis, Y., McMullan, D. M., and Emond, J. C. (1997) Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 121, 142-149 (Pubitemid 27091768)
4. Cataldegirmen, G., Zeng, S., Ippagunta, N., Dun, H., Qu, W., Lu, Y., Rong, L. L., Hofmann, M. A., Kislinger, T., Pachydaki, S. I., Jenkins, D. G., Weinberg, A., Lefkowitch, J., Rogiers, X., Yan, S. F., Schmidt, A. M., and Emond, J. C. (2005) RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J. Exp. Med. 201, 473-484 (Pubitemid 40229421)
5. Kawai, T., and Akira, S. (2007) TLR signaling. Sem. Immunol. 19, 24-32 (Pubitemid 46498752)
6. Burns, K., Martinon, F., Esslinger, C., Pahl, H., Schneider, P., Bodmer, J. L., Di Marco, F., French, L., and Tschopp, J. (1998) MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273, 12203-12209 (Pubitemid 28240584)
7. Ohmori, S., Mori, M., Kawase, M., and Tusboi, S. (1987) Determination of methylglyoxal as 2-methylquinoxaline by high-performance liquid chromatography and its application to biological samples. J. Chromatogr. 414, 149-155 (Pubitemid 17025776)
8. Bair III, W. B., Cabello, C. M., Uchida, K., Bause, A. S., and Wondrak, G. T. (2010) Glo1 overexpression in human malignant melanoma. Melanoma Res. 20, 85-96
9. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (Pubitemid 23259742)
10. Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y., and Hattori, M. (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res. 32, D277-D280 (Pubitemid 38081656)
11. Draghici, S., Khatri, P., Tarca, A. L., Amin, K., Done, A., Voichita, C., Georgescu, C., and Romero, R. (2007) A systems biology approach for pathway level analysis. Genome Res. 17, 1537-1545 (Pubitemid 47529438)
12. Cuypers, H. T., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., Van Wezenbeek, P., Melief, C., and Berns, A. (1984) Murine leukemia virus-induced T cell lymphomagenesis: integration of provirus in a distinct chromosomal region. Cell 37, 141-150 (Pubitemid 14079845)
13. Chen, X., Xu, C., Zhang, F., and Ma, J. (2010) Microarray approach reveals the relevance of interferon signaling pathways with rat liver restoration post 2/3 hepatectomy at the cellular level. J. Interferon Cytokine Res. 30, 525-539
14. Sowa, J. P., Benko, T., Bockhorn, M., Gu, Y., Niehues, E. M., Bucchi, A., Benedetto-Castro, E. M., Gerken, G., Rauen, U., and Schlaak, J. F. (2008) Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration. World J. Gastroenterol. 14, 7093-7100
15. Thornalley, P. J. (1993) The glyoxalase system in health and disease. Mol. Aspects Med. 14, 287-371
16. Yamada, Y., and Fausto, F. (1998) Deficient liver regeneration after carbon Tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152, 1577-1589 (Pubitemid 28275015)
17. Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., and Diehl, A. M. (1992) Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263, G579-G585
18. Wang, Z., Bhattacharya, N., Weaver, M., Petersen, K., Meyer, M., Gapter, L., and Magnuson, N. S. (2001) Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J. Vet. Sci. 2, 167-179
19. Zemskova, M., Sahakian, E., Bashkirova, S., and Lilly, M. (2008) The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. J. Biol. Chem. 283, 20635-20644
20. Jin, X., Zhang, Z., Beer-Stoiz, D., Zimmers, T. A., and Koniaris, L. G. (2007) Interleukin-6 oxidative injury and necrosis after extreme liver resection. Hepatology 46, 802-812 (Pubitemid 47436127)
21. Cressman, D. E., Greeenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6 deficient mice. Science 274, 1379-1383 (Pubitemid 26391463)
22. Brakenhoff, J. P., de Hon, F. D., Fontaine, V., ten Boekel, E., Schooltink. H., Rose-John, S., Heinrich, P. C., Content, J., and Aarden, L. A. (1994) Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269, 86-93 (Pubitemid 24026627)
23. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122 (Pubitemid 29359962)
24. Libermann, T. A., and Baltimore, D. (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10, 2327-2334
25. Bachmann, M., and Möröy, T. (2005) The serine/threonine kinase Pim-1. Int. J. Biochem. Cell Biol. 37, 726-730 (Pubitemid 40202995)
26. Hanse, E. A., Nelsen, C. J., Goggin, M. M., Anttila, C. K., Mullany, L. K., Berthet, C., Kaldis, P., Crary, G. S., Kuriyama, R., and Albrecht, J. H. (2009) Cdk2 plays a critical role in hepatocytes cell cycle progression and survival in the setting of cycline D1 expression in vivo. Cell Cycle 8, 2802-2809
27. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170
28. Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., and Heinecke, J. W. (1999) The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J. Clin. Invest. 104, 103-113 (Pubitemid 29534350)
29. Ramasamy, R., Yan, S. F., and Schmidt, A. M. (2009) RAGE: therapeutic target and biomarker of the inflammatory response - the evidence mounts. J. Leukoc. Biol. 86, 505-512
30. Matikainen, S., Sareneva, T., Ronni, T., Lehtonen, A., Koskinen, P. J., and Julkunen, I. (1999) Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2R alpha, c-myc, and pim-1 genes in human T cells. Blood 93, 1980-1991 (Pubitemid 29128500)
31. Buckley, A. R. (2000) Transcriptional regulation of pim-1 by prolactin: independence of a requirement for Jak2/Stat signaling. J. Neuroimmunol. 109, 40-46
32. Stout, B. A., Bates, M. E., Liu, L. Y., Farrington, N. N., and Bertics, P. J. (2004) IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 to promote Pim-1 and cyclin D3 protein expression in human eosinophils. J. Immunol. 173, 6409-6417 (Pubitemid 39487801)
33. Zhu, N., Ramirez, L. M., Lee, R. L., Magnuson, N. S., Bishop, G. A., and Gold, M. R. (2002) CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J. Immunol. 168, 744-754 (Pubitemid 34049575)
34. Endo, Y., Marusawa, H., Kinoshita, K., Morisawa, T., Sakurai, T., Okazaki, I. M., Watashi, K., Shimotohno, K., Honjo, T., and Chiba, T. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 26, 5587-5595 (Pubitemid 47267836)
35. Nihira, K., Ando, Y., Yamaguchi, T., Kagami, Y., Miki, Y., and Yoshida, K. (2010) Pim-1 controls NF-kB signaling by stabilizing RelA/p65. Cell Death Differ. 17, 689-698
36. Mochizuki, T., Kitanaka, C., Noguchi, K., Muramatsu, T., Asai, A., and Kuchino, Y. (1999) Physical and functional interactions between Pim1 kinase and Cdc25A phosphatase. Implications for the Pim-1 mediated activation of the c-myc signaling pathway. J. Biol. Chem. 274, 18659-18666
37. Bachmann, M., Kosan, C., Xing, P. X., Montenarh, M., Hoffmann, I., and Moroy, T. (2006) The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. Int. J. Biochem. Cell Biol. 38, 430-443 (Pubitemid 41821890)
38. Wang, Z., Bhattacharya, N., Mixter, P. F., Wei, W., Sedivy, J., and Magnuson, N. S. (2002) Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim. Biophys. Acta 1593, 45-55 (Pubitemid 35335911)
39. Meloche, J., Paulin, R., Courboulin, A., Lambert, C., Barrier, M., Bonnet, P., Bisserier, M., Roy, M., Sussman, M. A., Agharazii, M., and Bonnet, S. (2011) RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling process. Arterioscler. Thromb. Vasc. Biol. 31, 2114-2124
40. Loppnow, H., and Libby, P. (1990) Proliferating or interleukin-1 activated human vascular smooth muscle cells secrete copious interleukin 6. J. Clin. Invest. 85, 731-738 (Pubitemid 20087475)
41. Kluwe, J., Mencin, A., and Schwabe, R. F. (2009) Toll-like receptors, wound healing, and carcinogenesis. J. Mol. Med. (Berl.) 87, 125-138
42. Taub, R. (2004) Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell. Biol. 5, 836-847